WCN26-2234 A Randomised Controlled Trial of Tripterygium wilfordii polyglycoside in the Treatment of Stage IV Diabetic Nephropathy

Authors
Category Primary study
ConferenceKidney international reports
Year 2026
This article has no abstract
Epistemonikos ID: 3fc78a09ddf306a9ec24194b672c1da9a3b3345b
First added on: Jun 27, 2026